Related by context. All words. (Click for frequent words.) 67 logistic regression models 65 gamma logs 65 Multivariate logistic regression 64 Descriptive statistics 64 Multiple linear regression 63 conditional logistic regression 63 Logistic regression 63 Multiple logistic regression 62 Cronbach alpha 62 immunohistochemical analysis 62 convergent validity 62 reservoir permeability 62 Pharmacokinetic parameters 61 logistic regression analyzes 61 Kaplan Meier survival 61 histopathologic 61 Multivariate analysis 61 multiple logistic regression 61 Column leach 61 caustic fusion diamond 61 Subgroup analyzes 61 meta analytic 61 chi squared 61 multivariate logistic regression 61 Multivariable logistic regression 61 leachability 61 Bonferroni 60 multivariate regression 60 nonparametric 60 binomial model 60 intact parathyroid hormone 60 AST ALT 60 interobserver 60 variography 60 residual confounding 60 Kaplan Meier analysis 59 bivariate 59 urodynamic 59 reproducible measurements 59 chest radiographs 59 confidence intervals CIs 59 Bonferroni correction 59 oncologic outcomes 59 histologic findings 59 Randomized clinical trials 59 MDRD 59 sensitivity specificity 59 serum lipid 59 microsimulation model 59 Logistic regression analyzes 59 Subgroup analysis 59 plasma pharmacokinetics 59 Cochrane reviewers 59 pharmacodynamic PD 59 multivariable logistic regression 59 predictive validity 59 univariate 59 flotation testwork 59 intraobserver 59 Kaplan Meier curve 59 Poisson regression 58 Linear regression 58 Bulk density 58 heap leach recoveries 58 multiple linear regression 58 histopathological 58 Logistic regression analysis 58 Kaplan Meier curves 58 multivariate regression analysis 58 Meta analyzes 58 Randomised controlled trials 58 mineralogical analysis 58 Post hoc 58 meta regression 58 statistical significance p 58 Flow cytometry 58 histopathological examination 58 chromatograms 58 Updated Feasibility Study 58 Metallurgical testwork 58 gauge vitrectomy 58 electrophysiologic 58 correlational 58 Randomized trials 58 subgroup analyzes 58 True thicknesses 58 Univariate 58 metabolite concentrations 58 Testwork 58 mineralogical studies 58 Primary endpoints 58 logistic regression analysis 58 histopathologic diagnosis 58 Observational studies 58 transthoracic 58 Kaplan Meier method 57 Mantel Haenszel 57 Pharmacodynamic 57 grindability 57 Kaplan Meier 57 Liver biopsy 57 PSA kinetics 57 dosimetric 57 myocardial viability 57 Wireline logs 57 pharmacodynamic parameters 57 logistic regression model 57 Multivariate analyzes 57 Regression analyzes 57 logistic regression 57 multivariate Cox 57 Cardiorespiratory fitness 57 MTT assay 57 pulp metallic 57 endoscopic gastric ulcers 57 scintigraphic 57 histopathologic examination 57 Pearson correlation coefficient 57 prospectively defined 57 O PPDS 57 Plain radiographs 57 Histologic 57 logistic regressions 57 viral kinetics 57 Histopathologic 57 grade interpolation 57 bivariate analysis 57 immunohistochemical 57 ROC curves 57 unmeasured confounding 57 reliabilities 57 nonrandomized 57 inferential statistics 57 odds ratios ORs 57 stepwise logistic regression 56 variograms 56 NIHSS score 56 prospective multicenter study 56 Rougher flotation 56 percutaneous vertebroplasty 56 dose proportionality 56 Echocardiographic 56 reagent consumption 56 perioperative morbidity 56 regression coefficients 56 NPVs 56 CSAMT MT 56 linear regression analyzes 56 PCI ExTRACT TIMI 56 hip resurfacing arthroplasty 56 glomerular filtration 56 serum phosphorous 56 radiation dosimetry 56 ADCS ADL 56 genotypic resistance 56 polygonal method 56 MERLIN TIMI 56 Symptom severity 56 echocardiographic parameters 56 plain radiographs 56 metallurgical flowsheet 56 coronary CTA 56 prognostic indicators 56 mg/m2 cohort 56 preliminary metallurgical testwork 56 nonrandomized studies 56 F FDG PET 56 Regression analysis 56 aminotransferase levels 56 SYNTAX trial 56 ConclusionThis 56 prospectively stratified 56 ENRICH trial 56 interobserver reliability 56 variance ANOVA 56 Zevalin consolidation 56 exploratory endpoints 56 postprocedure 56 Pearson correlation coefficients 56 Repeatability 56 vitro experiments 56 geochemical assay 55 explanatory variables 55 endometrial biopsy 55 morphometric vertebral fractures 55 posttest 55 morphometric analysis 55 intraclass correlation coefficient 55 metabolic parameters 55 pharmacodynamic markers 55 specified secondary endpoints 55 Kruskal Wallis test 55 Geotechnical drilling 55 proximal femur 55 PRIMO CABG 55 linear regressions 55 postoperative chemotherapy 55 hydrocarbon saturations 55 null hypothesis 55 univariate analyzes 55 acid soluble 55 selenium supplementation 55 HER2 expression 55 nonsampling errors 55 histopathologic findings 55 autocorrelation 55 histological examination 55 metallurgical recoveries 55 Preliminary metallurgical 55 pharmacodynamic properties 55 pharmacokinetic PK profile 55 econometric analyzes 55 spirometric 55 methodologic 55 pharmacokinetic characteristics 55 colonoscopic 55 magnetic susceptibility 55 Confirmatory 55 Liver biopsies 55 glutamate glutamine 55 gravimetric method 55 attenuation correction 55 flotation cyanidation 55 psychometric properties 55 retest reliability 55 definite stent thrombosis 55 corrected QT interval 55 unmeasured confounders 55 retrospective observational study 55 postintervention 55 Platelet counts 55 Heap leach 55 FDG-PET/CT 55 PRIMO CABG2 55 urine cytology 55 nomograms 55 noninferiority 55 mg BID dose 55 Multivariable 55 SYMMETRY trial 55 serum clusterin levels 55 mineralized envelopes 55 Taysan Project 55 Pharmacokinetic PK 55 semiquantitative 55 eU#O# 55 randomized controlled trials RCTs 55 HBV infections 55 Univariate analysis 55 kriging 55 ultrastructural 55 trastuzumab emtansine T DM1 55 GAMMAGARD 55 Non inferiority 55 multivariable analysis 55 ultrasonographic 55 cyanide extraction 55 RQ PCR 54 HOMA IR 54 preclinical pharmacokinetic 54 Mineral Resource estimates 54 macrodiamond 54 bazedoxifene conjugated estrogens 54 serum biomarkers 54 generalized estimating 54 transcriptomic 54 lognormal 54 regression equations 54 confirmatory clinical 54 coronary stenosis 54 echocardiographic 54 mineral zonation 54 kurtosis 54 multivariable Cox 54 analgesic efficacy 54 serum markers 54 phylogenetic analyzes 54 ADAS cog 54 Histopathological 54 flowsheets 54 clinicopathologic 54 Duration Gap 54 mineability 54 cardiac perfusion 54 albumin excretion 54 underlying sulfide mineralization 54 postoperative mortality 54 EDEMA3 trial 54 hsCRP levels 54 adenoma recurrence 54 pharmacokinetic equivalence 54 pharmacokinetic PK 54 Androxal TM 54 Enzyme Leach soil 54 Raman spectra 54 nonclinical studies 54 VTEM airborne surveys 54 adjuvant systemic 54 sulphide mineralization intersected 54 metal zonation 54 Phylogenetic analyzes 54 d dimer 54 sedimentological 54 HERmark assay 54 multivariate analyzes 54 STRIDE PD 54 commercially producible 54 postoperative radiographs 54 mean ± SEM 54 generalized linear 54 mTOR inhibition 54 regression analyzes 54 Mineralized intervals 54 ultrasound elastography 54 Ordinary kriging 54 Monte Carlo simulations 54 heap leach amenability 54 DEXA scans 54 KRAS mutation status 54 reaction kinetics 54 Theoretical calculations 54 transabdominal 54 Geochemical analyzes 54 renal biopsy 54 follicular adenoma 54 ICP MS AAS 54 XIENCE V PROMUS Stent 54 neurodevelopmental outcome 54 FDG PET imaging 54 artifactual 54 biopsied tissue 54 periprocedural 54 orofacial clefts 54 ADAGIO study 54 hepatic arterial 54 factorial 54 thorough QT 54 microdiamond 54 urinary N telopeptide 54 interobserver agreement 54 macrodiamonds 54 color Doppler sonography 54 liver biopsies 54 glycosylated hemoglobin HbA1c 54 etiologic 54 Prefeasibility Study 54 Introductory teaser rates 54 antiangiogenic activity 54 radiographic outcomes 54 prespecified secondary 54 Metallurgical recoveries 54 multivariable analyzes 54 linear extrapolation 54 tissue microarrays 54 QTc prolongation 54 Interrater reliability 54 bile acid metabolism 54 HyQ 54 intraventricular 54 microstructural 54 sonographic findings 54 bronchopulmonary dysplasia BPD 54 pCR 54 PSADT 54 myocardial necrosis 54 arthrography 53 ARB telmisartan 53 pharmacodynamic endpoints 53 absorption spectra 53 HIV tropism 53 elective PCI 53 neurocognitive function 53 carotid IMT 53 AVERROES 53 prognostic significance 53 differential gene expression 53 antipsychotic efficacy 53 Alternative Scenarios 53 coagulation parameters 53 clinicopathological features 53 cytologic 53 SIMPADICO 53 portable XRF analyzer 53 FDG PET CT 53 NP CRNs 53 WOMAC pain 53 upon Trevali metallurgical 53 geological geophysical geochemical 53 TAXUS VI 53 pairwise comparisons 53 attain statistical significance 53 pharmacodynamic effects 53 resistivity measurements 53 PCWP 53 ExTRACT TIMI 53 petrographic studies 53 probabilistic methods 53 osteoid 53 enzyme kinetics 53 observational cohort 53 downhole geophysics 53 HbA 1C 53 transvaginal sonography 53 BIF outcrops 53 RE LY ® 53 binary logistic regression 53 Soil geochemistry 53 hydrogeologic 53 immunohistochemical staining 53 neurologic outcomes 53 recursive partitioning 53 SLNB 53 Finite element 53 Phase Ib study 53 heap leach processing 53 transrectal ultrasound 53 NHAMCS 53 SVR# 53 CTEPH 53 QT QTc 53 multivariable regression 53 reassayed 53 APOE genotype 53 favorable pharmacokinetic profile 53 Doppler echocardiography 53 K ras mutations 53 symptomatic VTE 53 NHANES III 53 process flowsheet 53 psychopathological symptoms 53 parameter estimation 53 HORIZONS AMI trial 53 surrogate markers 53 periprocedural MI 53 MEND CABG 53 bepotastine besilate nasal spray 53 secondary efficacy endpoint 53 hematologic parameters 53 ANCOVA 53 Wytowno # 1 53 Postoperative complications 53 ANOVA 53 covariate 53 posttreatment 53 Mendelian randomization 53 neuropathological 53 Darnley Bay gravity 53 ADAS Cog 53 subtrochanteric 53 Supplementary Table 53 perioperative mortality 53 mITT population 53 Fracture stimulation 53 Radiographs 53 bovine thrombin 53 PROactive study 53 placebo controlled trials 53 galiximab 53 astatine 53 MET amplification 53 relapsed MM 53 nanoparticle toxicity 53 left ventricular diastolic 53 NIHSS 53 NAMCS 53 variogram 53 SLN biopsy 53 peak VO2 53 chemosensitivity 53 eigenvalues 53 enzyme immunoassay EIA 53 Bayesian statistical 53 foveal thickness 53 Silverstreams 53 Mechanistic studies 53 Rigorous scientific 53 Secondary efficacy endpoints 53 airborne magnetic anomalies 53 skin sterol 53 Figure 2a 53 alkaline leaching 53 CARE HF 53 coronary arteriography 53 florbetaben 53 ID2 53 intima media thickness 53 clinico pathological 53 dietary carbohydrate 53 TAXUS V 53 MMSE score 53 posterolateral fusion 53 histologic 53 pharmacokinetic parameters 53 coal seam thickness 53 interrater 53 NSQIP 53 intraclass correlation coefficients 53 vitro dissolution 53 MTWA testing 53 antiangiogenic agents 53 randomized Phase 2b 53 MTHFD1L gene 53 conventional angiography 53 antineutrino 53 nucleotide substitutions 53 PIB PET 53 D dimer 53 MoxDuo TM IR 53 creatinine clearance CrCl 53 structural lineaments 53 clinicopathological 53 HQ diameter 53 Statistical analyzes 53 Extension Occurrence 53 realizability 53 echogenicity 53 myocardial uptake 53 Young modulus 53 #F FDG PET 53 flowsheet 53 Mineral Resource estimation 53 colorectal adenoma 53 PROPEL trial 53 flotation tailings 53 FDG uptake 53 dichotomous variables 52 interrater reliability 52 myocardial perfusion 52 inferred resource calculation 52 CLIRS 52 dose Iluvien 52 mediated dilation 52 metaanalysis 52 physiologic responses 52 pure fructose 52 PROLACRIA 52 gravity geophysical surveys 52 androgen depletion 52 transesophageal 52 ventricular dyssynchrony 52 gamma logging 52 FDG PET 52 carotid artery thickness 52 nodal metastases 52 demonstrated clinically meaningful 52 argon argon dating 52 antemortem 52 physico chemical properties 52 preclinical efficacy 52 nomogram 52 PSA nadir 52 anthropometric measures 52 AVADO 52 adit sampling 52 pathologic diagnosis 52 oxide sulphide 52 generalisability 52 Miguel Auza 52 EmbraceAC 52 splice variants 52 morphologic 52 Sensitivity Analysis 52 transient elastography 52 Coronary angiography 52 inhibin B 52 preoperative diagnosis 52 petrological 52 R# #mg BID 52 clinical endpoints 52 Microscopic examination 52 Drill intersections 52 ICP AES Method 52 IFRS changeover 52 HERmark 52 intravascular ultrasonography 52 androgen suppression 52 pharmacokinetics PK 52 chest radiography 52 unobservable inputs 52 eculizumab therapy 52 Tumor Response 52 indicator kriging 52 previously unsampled 52 microarray gene expression 52 prognostic variables 52 squared ID2 52 riociguat 52 Dose escalation 52 x ray crystallographic 52 valvulopathy 52 radiographic findings 52 NADiA 52 OBPM 52 Coronary calcium 52 RVOT 52 silica pyrite 52 serum cotinine 52 CIMZIA ™ 52 NATRECOR ® 52 Aricheng West 52 caustic dissolution 52 GLJ Report 52 renal cysts 52 prospective observational studies 52 Pharmacokinetic studies 52 Neuradiab 52 MAGE A3 ASCI 52 venous oxygen saturation 52 Secondary endpoints 52 HAQ DI 52 prospective multicentre 52 dosage regimens 52 element ICP analysis 52 secondary efficacy endpoints 52 cardiac repolarization 52 MR angiography 52 femoral component 52 Y BOCS 52 physicochemical properties 52 surface geochemistry 52 AUA Symptom Score 52 serum homocysteine 52 BEXXAR Therapeutic Regimen 52 Baseline characteristics 52 formal pharmacokinetic PK 52 Wilcoxon rank sum 52 CT perfusion 52 mineable reserve 52 NITON 52 NRF2 gene 52 paraffin embedded tissue 52 PET tracers 52 familial aggregation 52 mammographic density 52 corneal thickness 52 atherosclerotic renal artery stenosis 52 IP induced polarization 52 serum urate 52 CORE OM 52 Correlation coefficients 52 ImmuKnow assay 52 eTag assays 52 testwork carried 52 acetabular fracture 52 petrography 52 heap leachable 52 vein widths 52 bioprosthetic valve 52 conventional coronary angiography 52 Drill composites 52 Glomerular filtration rate 52 DLTs 52 virologic responses 52 niobium mineralization 52 Bracketed figures 52 antidepressant efficacy 52 anomalous geochemical 52 allele frequencies 52 parasitological 52 oncological outcomes 52 MDRD equation 52 covariance 52 DLQI 52 tumor biopsies 52 dacarbazine chemotherapy 52 biostatistical analysis 52 angiographic outcomes 52 prospective longitudinal 52 adnexal mass 52 ADCS CGIC 52 ACCORD Lipid 52 Diamyd r vaccine 52 linear regression 52 Epidemiologic studies 52 parenchymal 52 serum PTH 52 serum lipid levels 52 2 methoxyestradiol #ME# 52 SUVmax 52 Brief Psychiatric 52 carotid plaque 52 PM#.# exposure 52 undiscounted cash 52 HCV RESPOND 2 52 methylation markers 52 percutaneous biopsy 52 gamma ray logs 52 antiangiogenic therapy 52 conductivities 52 Angiographic 52 elotuzumab 52 UKPDS 52 covariance ANCOVA 52 metallurgical characteristics 52 Previous epidemiological studies 52 ToGA 52 radiometric measurements 52 generalisable 52 lipoprotein profiles 52 IP Resistivity 52 cTnI 52 antioxidant supplementation 52 Dietary intakes 52 quantitative EEG 52 Au eqv oz 52 #S rRNA gene 52 bronchial lavage 52 LDL HDL 52 geochemical analyzes 52 Significant assay 52 chromatogram 52 perfusion defect 52 PITX2 methylation 52 induced sputum 52 injectivity test 52 pivotal bioequivalence 52 microdose 52 pharmacodynamics PD 52 audiometric 52 #/lb Mo 52 Proved undeveloped reserves 51 APTIMA HPV 51 radical cystectomy 51 xxxi adverse tax 51 Skin sterol 51 hole NFX# 51 ascertainment bias 51 femoral neck fracture 51 preoperatively 51 multivariable adjusted 51 methodologically rigorous 51 psychiatric comorbidity 51 volumetric calculations 51 eNO 51 reprocessed 2D seismic 51 Microarray analysis 51 tolerability pharmacokinetics 51 VADT 51 sitaxsentan 51 South Minita 51 PIX# [002] 51 Creatinine 51 albumin excretion rate 51 geologic interpretations 51 leach recoveries 51 semi variograms 51 axial length 51 vasogenic edema 51 linear regression analysis 51 Coronary CTA 51 biochemical recurrence 51 Buglova 51 crustal thickness 51 GRAVITAS trial 51 Histopathologic examination 51 Phase IIB 51 prostate carcinogenesis 51 Riviere Dore 51 Lumbar spine 51 producibility 51 microbiologic 51 rheological 51 Condition Classification 51 quantifications 51 kimberlite lithologies 51 Serrote Deposit 51 EuroSCORE 51 acid chloride 51 endometrial thickness 51 IV bisphosphonates 51 COSTAR II 51 lymphadenectomy 51 MPRs 51 reanalysed 51 dyssynchrony 51 pharmacokinetic interactions 51 paleoclimatic 51 Adumbi Prospect 51 PASI scores 51 placebo controlled clinical trials 51 RNFL thickness 51 chromites 51 inflammatory biomarkers 51 anthropometric measurements 51 serum BDNF 51 Creston Molybdenum Deposit 51 DSMB recommended 51 haematologic 51 NEUVENGE 51 MarginProbe 51 volumetrics 51 TMPRSS2 ERG fusion 51 Perkinamine 51 VSDs 51 chrome diopside 51 body habitus 51 carcinogenicity studies 51 symptom exacerbation 51 prospective observational cohort 51 chargeability highs 51 undetectable HBV DNA 51 Choco Mine 51 univariate analysis 51 downhole gamma probe 51 rALLy trial 51 alicaforsen enema 51 thyroglobulin 51 ABCSG 51 inhomogeneity 51 tumor histology 51 rebleeding 51 urodynamic parameters 51 immunostaining 51 alemtuzumab MS 51 HRQL 51 Trofex 51 inhomogeneities 51 Preoperatively 51 Prostate AdenoCarcinoma Treatment 51 hindfoot 51 macrocrystic 51 SpCO 51 CT urography 51 unpaired t 51 pole dipole 51 Kasala Main Zone 51 borehole geophysics 51 histologic diagnosis 51 vaginal progesterone gel 51 Anomalous radioactivity 51 vat leaching 51 HCV antibody 51 serum PSA 51 radiographically 51 PACCE trial 51 Scale cognitive subscale 51 phylogenetic relationships 51 GIK infusion 51 Thalomid ® 51 FOSRENOL ® 51 EQ 5D 51 search ellipsoid 51 specific antigen PSA 51 MMI geochemistry 51 corneal topography 51 pain palliation 51 Carotid Revascularization Endarterectomy vs. 51 viral kinetic 51 realizable value 51 Raman spectroscopic 51 Monte Carlo Simulation 51 Isidora Mine 51 lithological controls 51 liver transaminases 51 basal till 51 IMPACT DCM 51 electrocardiographic 51 dimensional echocardiography 51 SCK difficulty 51 hemodynamic parameters 51 interpretable 51 antiangiogenic agent 51 IP Resistivity survey 51 petrographic analysis 51 6MWD 51 antitumor effect 51 DFT calculations 51 Reproducibility 51 serum cortisol 51 DAS# scores 51 platinum Pt 51 Early Joli Fou 51 Longitudinal studies 51 IMPROVE HF 51 sigmoid 51 BUSM researchers 51 Turnagain deposit 51 acetabular fractures 51 outcrop exposures 51 helium isotopes 51 fluorimetry 51 endometrial carcinoma 51 atomic absorption methods 51 lactate dehydrogenase 51 Tanis Mesa 51 BRIM3 51 β blockers 51 pharmacokinetic studies 51 ventricular tachyarrhythmia 51 angiographically 51 assaying protocols 51 Nyafe 51 Dextofisopam 51 geological interpretations 51 OPCAB 51 transcranial Doppler 51 correlation coefficients 51 urodynamic studies 51 noninferior 51 carotid stenosis 51 FDG PET scans 51 Pharmacokinetic analysis 51 troponins 51 computed tomographic 51 NMP# 51 Intermountain Risk Score 51 ANCHOR trial 51 unoxidized 51 mechanistic studies 51 mineralogical characteristics 51 Phase #/#a clinical 51 Magnetic susceptibility 51 graft patency 51 petrographic 51 clinically meaningful improvement 51 atherosclerotic lesion 51 sulphide occurrences 51 WikiWealth.com s 51 neuroanatomical 51 JORC compliant Mineral Resource 51 proportional hazards 51 vein swarms 51 Ceplene/IL-2 51 SpHb monitoring 51 estimated glomerular filtration 51 STEP BD 51 Wona SW Zone 51 flowrate 51 portable XRF 51 Minita deposit 51 HRQOL 51 Magnetic resonance 51 Previous observational studies 51 Pharmacokinetic 51 PDP MLR 51 apparent diffusion coefficient 51 Cockcroft Gault 51 everolimus eluting stents 51 stent graft placement 51 t/m3 51 subcutaneous PRO 51 multicenter trials 51 Solorel 51 CardioPET 51 hemostatic efficacy 51 DAS# CRP 51 footwall zones 51 pelvic ultrasound 51 Tasigna prolongs 51 morphologic characteristics 51 extracolonic findings 51 tracer uptake 51 adenoma detection 51 morphometric 51 logit 51 computed tomographic scan 50 β carotene 50 Likert scale 50 elemental composition 50 electro magnetic EM 50 lithologic 50 cosmological parameters 50 urocortin 2 50 mineralogical characterization 50 neurosensory 50 exhaled nitric oxide 50 Cronbach 50 elevated LDH 50 mediastinal lymph nodes 50 perfusion abnormalities 50 favorable pharmacokinetic 50 quantitative computed tomography 50 NIH CPSI 50 fluid inclusions 50 PSMA ADC 50 Alzheimer Disease Assessment 50 arsenic antimony mercury 50 indibulin 50 biopsy specimens 50 copper molybdenum silver 50 Mineralized material 50 micrometer scale 50 computed tomographic scans 50 using ordinary kriging 50 metastatic HRPC 50 Bejucosa 50 premorbid 50 CLIRS trial 50 crizotinib PF # 50 Earthquake magnitudes 50 parametrically 50 flotation concentrate 50 concomitant medications 50 pathogenetic mechanisms 50 Preliminary metallurgical testwork 50 DSM IV diagnoses 50 atomic emission spectrometry 50 bioequivalency 50 cortical activation